Globe NewsWire News Distribution Service

Details

Written by Globe NewsWire Press Releases

Category: Globe NewsWire News Distribution Service

Published: 12 December 2024

Created: 12 December 2024

Last Updated: 12 December 2024

PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of an underwritten public offering of 7,400,000 common shares and warrants to purchase 7,400,000 common shares…

Posted: 2024-12-12 04:54:00

Get Full News Story On GlobeNewsWire Press Release Service

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

• Prev
• Next

Related Bing News Search Results

Press Release: BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering - Newscast

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Mon, 28 Apr 2025 13:05:00 GMT PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp ... manager for the offering. This press release shall not constitute an offer to ...

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Mon, 28 Apr 2025 13:05:00 GMT PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage ...

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Mon, 28 Apr 2025 06:05:00 GMT PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the ...

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Fri, 25 Apr 2025 04:12:00 GMT PHILADELPHIA and VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell ...

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Wed, 23 Apr 2025 09:32:00 GMT PHILADELPHIA and VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell ...